Ad

FDA puts Zafgen's diabetes trial on hold

Zafgen Inc said on Monday the U.S. Food and Drug Administration (FDA) had placed a clinical hold on the investigational new drug application for a trial of its experimental diabetes drug.


FDA puts Zafgen's diabetes trial on hold FDA puts Zafgen's diabetes trial on hold Reviewed by jenisht on November 26, 2018 Rating: 5

No comments:

Powered by Blogger.